Infectious Diseases and Your Health

Part 1: Parasitic infections.- Satranidazole and my pharmaceutical research odyssey: a success story.- Amoebiasis revisited.- Cerebral malaria: players in the pathogenic mechanism and treatment strategies.- Role of white blood cells in immunopathogenesis of cerebral malaria.- Chemotherapy and experimental models of visceral leishmaniasis.- Human trichomoniasis.- Taeniasis and neurocysticercosis: emerging public health problems.- Helminth parasites: the cause of distress and diseases.- Neglected tropical diseases: a biosocial perspective. Part 2: Bacterial infections.- Autophagy: a potential anti-bacterial therapeutic target.- Antibiotics and antimicrobial resistance.- Nontuberculous mycobacteria: an update on infections caused, laboratory identification and their treatment.- Drugs under pre-clinical and clinical testing for the treatment of infections caused due to Staphylococcus aureus: an update.- Recurrentvulvovaginal infections: etiology, diagnosis, treatment and management.- Enterococci as nosocomial pathogen.- Dietary antioxidants and infectious diseases.- Probiotic lactobacilli, infection and immunomodulation.- Part 3: Viral infections.- HIV-AIDS: an unconquered immune-war.- Chikungunya fever: where are we today? - Epigenetics and infectious pathogens: interactions, ploy and perspectives.- Part 4: Fungal infections.- An update on sexually transmitted infections: an Indian context.- Candida: friend and foe of humans.

Professor (Dr.) Prati Pal Singh, an internationally renowned educationalist and scientist, works at the National Institute of Pharmaceutical Education and Research (NIPER), S. A. S Nagar, India. For his Ph.D. degree (1980), he worked at the Central Drug Research Institute, Lucknow, and did his post-doctorate at Stanford University Medical Centre, CA, USA (1986) and Ohio State University, OH, USA (1984-85). Prof. Singh was subsequently a visiting fellow at Montreal General Hospital, Canada (1985). He is an eminent biotechnologist, parasitologist, microbiologist, immunologist and neuroimmunopharmacologist. Prof. Singh was involved in the pre-clinical development of satranidazole, a new anti-amoebic drug which is now on the market. He first reported on opiates as a new class of drugs for the treatment of parasitic/microbial infections, and has made important contributions to the control and treatment of malaria, tuberculosis, leishmaniasis, amoebiasis and trichomoniasis. Prof. Singh has co-edited three books: Water and Health (2014), Human Parasitic Infections of Pharmaceutical and National Health Importance (2009) and Biotechnical Approaches to Neuroimminumodulation and Infectious Diseases (2009). He has over 200 research publications including one in Nature Medicine, five editorials and nine patents including one US patent to his credit. Prof. Singh has been Editor-in-Chief of the Journal of Parasitic Diseases, and serves on the Editorial Board of the US journal J. Neuroimmune Pharmacology and several other international journals.  Prof. Singh was elected a Fellow of the National Academy of Sciences, India (2004) and Fellow of the Academy of Microbiological Sciences (2008), and was nominated for the fellowships of the Indian National Science Academy and Indian Science Academy. He was elected an At-Large Councilor (non-US) for the Society on Neuroimmune Pharmacology, USA in 2010. Prof. Singh was awarded the prestigious Bill and Melinda Gates